🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — 製薬実務の学習ノート

AIとがん研究 ── AML ── 2026-11-16

AML 1 本。筆頭: Development and validation of a machine learning model to predict the daily risk of febrile neutropenia in patients with AML undergoing chemotherapy

対象誌と選び方は索引の頁に

急性骨髄性白血病(AML)の治療・治験とAI

← この号の目次へ